Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Rien van Marwijk Kooij

Bortezomib Maintenance After R-Chop, Cytarabine and Autologous Stem Cell Transplantation in Newly Diagnosed Patients With Mantle Cell Lymphoma, Results of a Randomised Phase II HOVON Trial

British Journal of Haematology

Hematology

2020

English

Related publications

Decitabine Plus R-Chop in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma: Interim Results of a Phase I/Ii Study

Hematological Oncology

English

Lenalidomide and Obinutuzumab With Chop for Newly Diagnosed Diffuse Large B-Cell Lymphoma: Phase I/Ii Results

Hematological Oncology

English

Prognostic Variables of Progression Free Survival in Mantle Cell Lymphoma After Autologous Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2019

English

Evolution of Clonal Hematopoiesis in Mantle Cell Lymphoma Patients Before, During, and After Induction Chemotherapy and Autologous Stem Cell Transplantation

Hematological Oncology

English

Therapy With Bortezomib Plus Lenalidomide for Relapsed/Refractory Mantle Cell Lymphoma: Final Results of a Phase II Trial (CALGB 50501)

Leukemia and Lymphoma

English

Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma

Journal of Clinical Oncology

English

Phase 2 Trial of Rituximab and Bortezomib in Patients With Relapsed or Refractory Mantle Cell and Follicular Lymphoma

English

Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20+Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma

Journal of Clinical Oncology

English

Bortezomib Prevents Development of Cytarabine Resistance in a Mantle Cell Lymphoma in Vitro Model

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Rien van Marwijk Kooij

Bortezomib Maintenance After R-Chop, Cytarabine and Autologous Stem Cell Transplantation in Newly Diagnosed Patients With Mantle Cell Lymphoma, Results of a Randomised Phase II HOVON Trial

Related publications

Decitabine Plus R-Chop in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma: Interim Results of a Phase I/Ii Study

Lenalidomide and Obinutuzumab With Chop for Newly Diagnosed Diffuse Large B-Cell Lymphoma: Phase I/Ii Results

Prognostic Variables of Progression Free Survival in Mantle Cell Lymphoma After Autologous Stem Cell Transplantation

Evolution of Clonal Hematopoiesis in Mantle Cell Lymphoma Patients Before, During, and After Induction Chemotherapy and Autologous Stem Cell Transplantation

Therapy With Bortezomib Plus Lenalidomide for Relapsed/Refractory Mantle Cell Lymphoma: Final Results of a Phase II Trial (CALGB 50501)

Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma

Phase 2 Trial of Rituximab and Bortezomib in Patients With Relapsed or Refractory Mantle Cell and Follicular Lymphoma

Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20+Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma

Bortezomib Prevents Development of Cytarabine Resistance in a Mantle Cell Lymphoma in Vitro Model